Digital biomarkers — objective physiological and behavioral measures collected through digital devices that quantify health status and treatment response — are creating new SaMD clinical evidence infrastructure, with the Software as a Medical Device Market reflecting the development of validated digital biomarkers for neurological disease, psychiatric conditions, and chronic disease...